Modulation of Experimental Systemic Murine Candidosis by Intravenous Pepstatin
- 1 August 1990
- journal article
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 273 (3) , 391-403
- https://doi.org/10.1016/s0934-8840(11)80443-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of the aspartic proteinase from HIV‐2FEBS Letters, 1989
- Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin AFEBS Letters, 1989
- A second front against AIDSNature, 1989
- Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin AInternational Journal of Biochemistry, 1988
- Inhibition of retroviral protease activity by an aspartyl proteinase inhibitorNature, 1987
- The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strainThe Journal of Pathology, 1986
- Aspartic proteinases and their inhibitorsBiochemical Society Transactions, 1985
- Unilateral involvement of kidneys in mice infected withCandida albicansMedical Mycology, 1985
- The aspartic proteinase inhibitor pepstatin, enters mouse peritoneal macrophages by adsorptive pinocytosisCell Biology International Reports, 1983
- Circling syndrome and inner ear disease in mice infected intraperitoneally or intravenously with Coccidioides immitis spherule-endospore phase culturesMycopathologia, 1983